Long noncoding RNA: a new contributor and potential therapeutic target in fibrosis

Epigenomics. 2017 Sep;9(9):1233-1241. doi: 10.2217/epi-2017-0020. Epub 2017 Aug 15.

Abstract

Fibrosis is the excess deposition of extracellular matrix components which occur in multiple organs and ultimately leads to organ failure. Long noncoding RNAs (lncRNAs) are a kind of noncoding RNAs longer than approximately 200 nucleotides with no protein-encoding capacity. A growing body of evidence suggests that lncRNAs are also involved in tissues fibrosis in several organs, such as lungs fibrosis, liver fibrosis, renal fibrosis and cardiac fibrosis. In this review, we summarized the current studies of lncRNAs in the process of fibrosis and hopefully aid in better understanding the molecular mechanism of fibrosis and provide a basis to explore new therapeutic targets of fibrosis.

Keywords: extracellular matrix; fibrosis; long noncoding RNAs.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Fibrosis
  • Humans
  • Kidney / metabolism*
  • Kidney / pathology
  • Liver Cirrhosis / genetics*
  • Liver Cirrhosis / therapy
  • Myocardium / metabolism*
  • Myocardium / pathology
  • Pulmonary Fibrosis / genetics*
  • Pulmonary Fibrosis / therapy
  • RNA, Long Noncoding / genetics*

Substances

  • RNA, Long Noncoding